Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals, Inc. | Chief Financial Officer | $211K | -$400K | -65.4% | Oct 16, 2024 |
DRMA, DRMAW | Dermata Therapeutics, Inc. | Director | Jan 4, 2024 | |||
NKGN, NKGNW | NKGen Biotech, Inc. | Director | Feb 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|